TC BioPharm
Mark Hogg is an accomplished professional with a strong background in biopharmaceutical manufacturing and technical operations. Currently serving as Production Manager at TC BioPharm since October 2024, Mark oversees γδ T Cell Therapy manufacturing processes to GMP standards and manages daily production operations to align resources with business goals. Previously, Mark held various key positions at Piramal Pharma Solutions from March 2008 to October 2024, including Head of Technical Operations and Manufacturing Manager, where responsibilities encompassed ensuring efficient manufacturing operations, compliance with cGMP regulations, and leading production teams. Mark's career began as an Assistant Chemist at Fugro [ERT (Scotland) Ltd], with a solid educational foundation, holding a Bachelor of Science (BSc) Hons in Chemistry from Heriot-Watt University.
This person is not in any teams
TC BioPharm
TC BioPharm developing safer, cheaper, consistent and durable CAR-T drugs for hematological and solid tumors.